Futures Analysis
1
On-Chain Data
1
Technical Indicators
2
Institutional Data
1

Tharimmune

Biotechnology company(THAR)

About Tharimmune

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.

Community
Website
Tags
Digital Asset Treasury
Publicly listed company
Crypto Stocks

Trend of Hot Index Change

Investors

Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest

Fundrasing details

Post-IPO(2025-11-03)
Amount$540.00M
Investors
Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest
Valuation--